Add-on Acquisition • Life Science

Siegfried Holding Acquires hameln rds

On December 1, 2014, Siegfried Holding acquired life science company hameln rds

Acquisition Context
  • This is Siegfried Holding’s 1st transaction in the Life Science sector.
  • This is Siegfried Holding’s 2nd transaction in Germany.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date December 1, 2014
Target hameln rds
Sector Life Science
Buyer(s) Siegfried Holding
Deal Type Add-on Acquisition

Target Company

hameln rds

Hameln, Germany
hameln rds GmbH is a provider of product development, laboratory, and regulatory affairs services to pharmaceutical industries.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Siegfried Holding

Zofingen, Switzerland

Category Company
Founded 1873
Sector Life Science
Employees3,432
Revenue 1.3B CHF (2024)
DESCRIPTION

Siegfried Holding is a developer and manufacturer of active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediate steps and controlled substances, and provides development and production services for drugs in finished dosage forms including sterile filling. Siegfried Holding was founded in 1873 and is based in Zofingen, Switzerland.


Deal Context for Buyer #
Overall 2 of 2
Sector: Life Science 1 of 1
Type: Add-on Acquisition 2 of 2
Country: Germany 2 of 2
Year: 2014 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-01 hameln pharmaceuticals gmbh

Hameln, Germany

hameln pharmaceuticals gmbh is a pharmaceutical company offers liquid pharmaceutical products.

Buy -